To Compare the Effect of Different Nutritional Pathways on Improving Nutritional Status of Esophageal Cancer Patients Undergoing Chemoradiotherapy
This study prospectively recruited esophageal squamous-cell carcinoma patients who received nasogastric tube (NG), gastrostomy feeding and oral intake to compare the changes in nutritional status and quality of life during chemoradiation therapy (CRT).
Esophageal Squamous Cell Carcinoma|Chemoradiotherapy|Enteral Nutrition
DIETARY_SUPPLEMENT: Dietary guidance
Body Weight Change from baseline to the end of treatment, Body weight change from baseline to the end of treatment = body weight at the end of treatment - baseline body weight., up to 1 month after the treatment
Blood biochemical examination, albumin,prealbumin,haemoglobin,et al, record the changes before and after the treatment., up to 1 month after the treatment|Scored Patient-Generated Subjective Global Assessment (PG-SGA), Nutritional status evaluation table. score: 0-1 A: well-nourished; score：2-8 B: moderately malnourished; score：≥9 C: severely malnourished., up to 1 month after the treatment|EORTC QLQ-C30, Quality of life evaluation form. QLQ-C30 results were linearly transformed to scores 0 to 100. Higher scores represent worse symptoms in the symptom scales and better function in functional scales., up to 1 month after the treatment|Grade 3-5 toxicity, Grade 3-5 adverse events as assessed by NCI Common Toxicity Criteria for Adverse Effects (CTCAE) v3.0 andthe criteria of the Radiation Therapy Oncology Group ，such as esophagitis、pneumonitis 、hematologic toxicity and infection rate, up to 1 month after the treatment|Completion rate of chemoradiotherapy, The proportion of people who complete all treatment as required, up to 1 month after the treatment|Overall Survival, overall survival, at least 2 years
This study prospectively recruited esophageal squamous-cell carcinoma patients who received nasogastric tube (NG), gastrostomy feeding and oral intake to compare the changes in nutritional status and quality of life during chemoradiation therapy (CRT).